Back to Search

MARIO PADILLA

Addiction (Substance Use Disorder) Counselor

NPI: 1548737695Individual

Specialties, Licenses & Credentials

Addiction (Substance Use Disorder) CounselorPrimary

Counselor — Addiction (Substance Use Disorder)

Code: 101YA0400X

Clinical Trials (1)

1
Linked Trials
0
Recruiting
0
With Results

The Study of the Use of Nintedanib in Slowing Lung Disease in Patients With Fibrotic or Non-Fibrotic Interstitial Lung Disease Related to COVID-19

NCT04619680COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR

Research & Publications (1)

Early nintedanib deployment in COVID-19 interstitial lung disease (ENDCOV-I): study protocol of a randomised, double-blind, placebo-controlled trial.
PMID 40216412·BMJ Open Respir Res·2025
8-other

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Request Appointment

This provider isn't set up for online booking yet. Once you submit, we'll reach out to their office to arrange secure delivery of your request.

Contact & Hours

Address
226 W ONTARIO ST STE 400C
CHICAGO, IL 60654

Quick Facts

NPI
1548737695
Entity Type
Individual
Gender
Male
Medicare
Not confirmed
Specialties
1
Locations
1
Clinical Trials
1
Publications
1

Are you this provider?

Claim Your Profile